The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Clinical trial NCT00404768 · COMPLETED

Trial details

NCT number: NCT00404768
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obstetric Labour, Premature

Start date: 2007-10-12
Primary completion: 2011-07-07
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.